Wednesday, September 17, 2025 9/17/2025

Louisiana Assessment of Persons Presenting with Early and Late Stage HIV Diagnoses (LA-APPEALS) Study

Award Number: NU62PS924785
ORGANIZATION: NATIONAL CENTER FOR PREVENTION SERVICES
OPDIV: CDC
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: HEALTH SERVICES
PERIOD OF PERFORMANCE START DATE: 08/01/2022
PERIOD OF PERFORMANCE END DATE: 07/31/2026

Group Awards By:

View Award Description

Louisiana Assessment of Persons Presenting with Early and Late Stage HIV Diagnoses (LA-APPEALS) Study - Louisiana’s Enhanced Surveillance of Persons with Early and Late HIV Diagnosis to Understand System and Individual Factors Associated with New Infection and Delayed Testing Project Abstract Summary While we now have the tools to eliminate HIV within the United States, newly diagnosed cases still persist and represent potential missed opportunities of HIV prevention. Reasons for individual and system level barriers and facilitators of late testing as well as use of new biomedical prevention tools such as PrEP remain largely unknown. While other systems such as CDCs Medical Monitoring Project also examine some of these factors, they do not focus on new acute and late stage diagnoses and thus create a need for an additional supplemental system. The purpose of the current study then, is to create and implement a new system, the Louisiana Assessment of Persons Presenting with Early and Late Stage HIV Diagnoses (LA-APPEALS) study, to examine the factors associated with new acute and late stage HIV diagnoses nationally and in Louisiana. The Louisiana STD/HIV/Hepatitis Program (SHHP), the CDC, and a CDC contracted group of interviewers will collaborate to offer all newly identified HIV cases who present with either Stage 0 (i.e. acute) or Stage 3 (i.e. AIDS at time of diagnosis) HIV a brief behavioral survey about these individual and system level barriers and facilitators to HIV testing and access. Louisiana will abstract all early and late HIV diagnoses reported to the state eHARS surveillance system within the most recent 12 months and attempt to recruit and consent eligible individuals for participation in the survey. A later survey event will then be scheduled remotely by SHHP with the participant and administered the CDC contractor, who will remain blind to all identifying information and thus maintain participant anonymity. Ultimately this work should uncover valuable information on reasons behind early and late stage testing as well as PrEP unwillingness and inform development of new evidence-based interventions. By providing valuable and needed data on these populations, this project will ultimately lead to improvements in HIV prevention, treatment and testing services and thus reduce the spread of HIV both locally and nationally.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $234,247 )
2025	2025	HEALTH, LOUISIANA DEPARTMENT OF	1450 POYDRAS ST, STE 1652	NEW ORLEANS	LA	70112	ORLEANS	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	4	8/18/2025	NON-COMPETING CONTINUATION	$234,247
2025	2024	HEALTH, LOUISIANA DEPARTMENT OF	1450 POYDRAS ST, STE 1652	NEW ORLEANS	LA	70112	ORLEANS	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	4	8/18/2025	NON-COMPETING CONTINUATION	$0
2025	2023	HEALTH, LOUISIANA DEPARTMENT OF	1450 POYDRAS ST, STE 1652	NEW ORLEANS	LA	70112	ORLEANS	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	4	8/18/2025	NON-COMPETING CONTINUATION	$0
2025	2022	HEALTH, LOUISIANA DEPARTMENT OF	1450 POYDRAS ST, STE 1652	NEW ORLEANS	LA	70112	ORLEANS	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	4	8/18/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $234,247

Issue Date FY: 2024 ( Subtotal = $234,247 )
2024	2024	HEALTH, LOUISIANA DEPARTMENT OF	1450 POYDRAS ST, STE 1652	NEW ORLEANS	LA	70112	ORLEANS	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	3	7/8/2024	NON-COMPETING CONTINUATION	$234,247
2024	2023	HEALTH, LOUISIANA DEPARTMENT OF	1450 POYDRAS ST, STE 1652	NEW ORLEANS	LA	70112	ORLEANS	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	3	7/8/2024	NON-COMPETING CONTINUATION	$0
2024	2022	HEALTH, LOUISIANA DEPARTMENT OF	1450 POYDRAS ST, STE 1652	NEW ORLEANS	LA	70112	ORLEANS	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	3	7/8/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $234,247

Issue Date FY: 2023 ( Subtotal = $234,247 )
2023	2023	HEALTH, LOUISIANA DEPARTMENT OF	1450 POYDRAS ST, STE 1652	NEW ORLEANS	LA	70112	ORLEANS	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	2	6/30/2023	NON-COMPETING CONTINUATION	$234,247
2023	2022	HEALTH, LOUISIANA DEPARTMENT OF	1450 POYDRAS ST, STE 1652	NEW ORLEANS	LA	70112	ORLEANS	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	01	1	8/1/2023	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2023	2022	HEALTH, LOUISIANA DEPARTMENT OF	1450 POYDRAS ST, STE 1652	NEW ORLEANS	LA	70112	ORLEANS	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	2	6/30/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $234,247

Issue Date FY: 2022 ( Subtotal = $234,247 )
2022	2022	HEALTH, LOUISIANA DEPARTMENT OF	1450 Poydras St, Ste 1652	New Orleans	LA	70112	ORLEANS	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	1	7/20/2022	NEW	$234,247
														Subtotal = $234,247

Grand Total All Awards = $936,988

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Louisiana Assessment of Persons Presenting with Early and Late Stage HIV Diagnoses (LA-APPEALS) Study

Award Number: NU62PS924785

ORGANIZATION: NATIONAL CENTER FOR PREVENTION SERVICES

OPDIV: CDC

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: HEALTH SERVICES

PERIOD OF PERFORMANCE START DATE: 08/01/2022

PERIOD OF PERFORMANCE END DATE: 07/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer